Top Institutions in Ocular Oncology
Leading institutions in ocular oncology and cancer genomics utilize large patient cohorts, gene expression profiling, and biomarker validation studies, often collaborating with national cancer registries to validate prognostic tests like DecisionDx-UM and PRAME status.
-
#1
National Cancer Institute (NCI)
Bethesda, MD
NCI leads in cancer biomarker validation and large-scale population-based studies, including collaborations with SEER to link clinical and registry data for uveal melanoma prognostic research.
-
#2
Wills Eye Hospital
Philadelphia, PA
Wills Eye is a leading ocular oncology center with extensive clinical experience in uveal melanoma and active research in molecular prognostic testing and treatment strategies.
-
#3
Memorial Sloan Kettering Cancer Center
New York, NY
MSKCC integrates advanced genomic profiling in ocular tumors and conducts clinical trials and translational research on uveal melanoma prognostic markers and therapies.
-
#4
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has a strong ocular oncology program with research focused on molecular diagnostics and personalized medicine approaches for uveal melanoma.